Meet the organisers
Annika Bergquist
Annika Bergquist is a professor in gastroenterology and hepatology at Karolinska Institutet.
She earned her medical degree in 1992 and her PhD in 2002, focusing on bile duct cancer in primary sclerosing cholangitis (PSC). She is also a senior consultant at Karolinska University Hospital. Her research primarily targets autoimmune liver diseases, especially PSC and bile duct cancer, aiming to develop new diagnostic tools and treatments. She collaborates with national and international study groups and has contributed significantly to the field through numerous original publications, reviews and clinical guidelines.
Ansgar W. Lohse
Ansgar W. Lohse is a clinician scientist with a special interest in immune mediated liver diseases as well as infectious diseases.
He is the director of the I. Department of Medicine of the University Medical Centre Hamburg-Eppendorf. He studied medicine in Göttingen, London and Harvard Medical School, gained his doctoral degree at Marburg University and pursued his clinical and academic career at the Johannes Gutenberg-University in Mainz. He spent two years as a post-doctoral fellow at the Weizmann Institute of Science in Israel working on immune regulation.
He is a fellow of the American Association for the Study of the Liver, member of the Hamburg Academy of Sciences and a member of the senate of the German Research foundation. Since 2018 he is the coordinator of the European Reference Network for Hepatological Diseases (ERN RARE-LIVER).
Christoph Schramm
Prof. Dr. Christoph Schramm is senior consultant for hepatology and gastroenterology at the University Medical Center Hamburg-Eppendorf, Germany.
He is director of the Martin Zeitz Center for Rare Diseases and holds the Helmut and Hannelore Greve Foundation Chair for Rare Diseases. Prof. Schramm has a long standing interest in clinical and basic science of autoimmune liver diseases with a focus on primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and mechanisms of immune regulation in the liver. Prof. Schramm is spokesperson of the DFG-funded Collaborative Research Center CRC 1700 (“Immune regulation in the liver: from homeostasis to disease”). He contributed to several European practice guidelines on autoimmune liver diseases and co-coordinated the first German practice guideline on autoimmune liver diseases. Prof. Schramm is current secretary of the International PSC Study Group (IPSCSG) and is a board member of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER).